{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:15:54Z","timestamp":1788498954787,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is characterized by profound immune dysregulation, yet the biological significance and clinical application of peripheral immune phenotyping in sepsis remain incompletely defined. This study aimed to define internally identified immune phenotypes in sepsis and evaluate their prognostic and translational relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this single-centre retrospective cohort study, 374 adult patients with sepsis or severe infection were included. Six peripheral immune markers (total T cells, CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, total B cells, NK cells, and monocyte HLA-DR) together with clinically relevant laboratory indicators were analysed to characterize immune and clinical-laboratory heterogeneity in sepsis. Internal validity metrics were used to determine the optimal cluster number. The prognostic value of immune phenotypes was benchmarked against routine laboratory indicators through exhaustive combinatorial clustering and repeated cross-validated logistic regression. Associations with illness severity (SOFA, APACHE II, and NUTRIC) were further assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two internally stable immune phenotypes were identified: an immune-preserved phenotype (n = 306) and an immune-suppressed phenotype (n = 61). The immune-suppressed phenotype exhibited globally reduced lymphocyte subsets and lower monocyte HLA-DR, accompanied by lower platelet and white blood cell counts, higher inflammatory markers, and slightly higher SOFA scores. However, in-hospital mortality did not differ significantly between phenotypes (39.0% vs 30.6%, *P* = 0.224). Immune phenotyping achieved limited prognostic separation (\u0394 = 8.9 percentage points), substantially lower than laboratory-based combinations (\u0394 = 63.3 points). In predictive modelling, the six-marker immune model showed the weakest discrimination (AUC\u00a0=\u00a00.646 \u00b1 0.066), whereas SOFA alone outperformed all six-marker combinations (AUC\u00a0=\u00a00.747 \u00b1 0.055). Lactate, as a severity-associated laboratory indicator, demonstrated a stronger prognostic association than immune parameter suggesting that immune suppression and physiological stress represent complementary dimensions of sepsis pathobiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Peripheral immune phenotyping identifies biologically distinct immune-preserved and immune-suppressed states in sepsis. Although these immune phenotypes provide limited additional prognostic discrimination beyond established severity scores and routine laboratory indicators, they provide valuable insights into immune dysfunction and represent a potential framework for immune stratification. Further longitudinal studies are needed to determine whether these immune phenotypes can inform future personalized immunomodulatory strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1939205","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:26:17Z","timestamp":1788495977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral immune phenotyping identifies an immunosuppressed sepsis endotype with potential relevance for immune stratification"],"prefix":"10.3389","volume":"17","author":[{"given":"Rong","family":"Luo","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Jinan University, Department of Critical Care Medicine, Shenzhen People\u2019s Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Clinical Medical Research Center, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Deng","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Jinan University, Department of Critical Care Medicine, Shenzhen People\u2019s Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengying","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Jinan University, Department of Critical Care Medicine, Shenzhen People\u2019s Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Clinical Medical Research Center, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medical Research Center, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, Guangdong, China"]},{"name":"Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Department of Geriatrics, Shenzhen People\u2019s Hospital, the First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College of Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaisheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)","place":["Shenzhen, Guangdong, China"]},{"name":"Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Department of Geriatrics, Shenzhen People\u2019s Hospital, the First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College of Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.628302","article-title":"Sepsis\u2014pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CNQ.0000000000000570","article-title":"Sepsis epidemiology, definitions, scoring systems, and diagnostic markers","volume":"48","author":"Modugula","year":"2025","journal-title":"Crit Care Nurs Q"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003342","article-title":"Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level","volume":"46","author":"Paoli","year":"2018","journal-title":"Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0014","article-title":"Detection of early cytokine storm in patients with septic shock after abdominal surgery","volume":"8","author":"Chao","year":"2020","journal-title":"J Transl Int Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jtim-2026-0017","article-title":"Reframing sepsis research through translational integrative models","volume":"14","author":"Zhu","year":"2026","journal-title":"J Transl Int Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2025-0035","article-title":"NETosis and pyroptosis of immune cells in sepsis","volume":"13","author":"Kashif","year":"2025","journal-title":"J Transl Int Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130214","article-title":"Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis","volume":"14","author":"Joshi","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08110-w","article-title":"Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases","volume":"51","author":"Monneret","year":"2025","journal-title":"Intensive Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1404664","article-title":"Parallels between cancer and infectious disease","volume":"371","author":"Hotchkiss","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1731995","article-title":"Immunometabolic reprogramming in sepsis: mechanisms, clinical endotypes, and therapeutic opportunities","volume":"17","author":"Liu","year":"2026","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03964-5","article-title":"A consensus blood transcriptomic framework for sepsis","volume":"31","author":"Scicluna","year":"2025","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1138","article-title":"An integrative model with HLA-DR, CD64, and PD-1 for the diagnostic and prognostic evaluation of sepsis","volume":"12","author":"Chen","year":"2024","journal-title":"Immun Inflammation Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1498974","article-title":"Time-dependent variation in immunoparalysis biomarkers among patients with sepsis and critical illness","volume":"15","author":"Samuelsen","year":"2024","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1109\/LSP.2014.2337313","article-title":"Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves","volume":"21","author":"Sun","year":"2014","journal-title":"IEEE Signal Process Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70561","article-title":"Sepsis endotypes defined by lymphocyte thresholds and inflammation inform precision immunomodulation","volume":"7","author":"Sun","year":"2026","journal-title":"MedComm (2020)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2025-0094","article-title":"Unfractionated heparin improves coagulation in sepsis by protecting glycocalyx of endothelia cells through inhibiting heparinase","volume":"13","author":"Zhang","year":"2025","journal-title":"J Transl Int Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.955991","article-title":"Pyroptosis in sepsis: comprehensive analysis of research hotspots and core genes in 2022","volume":"9","author":"Xia","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/15476278.2023.2177484","article-title":"The role of Gasdermin-D-mediated pryoptosis in organ injury and its therapeutic implications","volume":"19","author":"Mulla","year":"2023","journal-title":"Organogenesis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2403213","article-title":"Sepsis and septic shock","volume":"391","author":"Meyer","year":"2024","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3283532c08","article-title":"The holistic view on perfusion monitoring in septic shock","volume":"18","author":"Hernandez","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2478\/jtim-2024-0004","article-title":"WWP2 protects against sepsis-induced cardiac injury through inhibiting cardiomyocyte ferroptosis","volume":"12","author":"Li","year":"2024","journal-title":"J Transl Int Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008","volume":"34","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13054-026-05957-3","article-title":"New-onset septic shock in the ImmunoSep trial","volume":"30","author":"Zhang","year":"2026","journal-title":"Crit Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1939205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:26:18Z","timestamp":1788495978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1939205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2026.1939205"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1939205","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1939205"}}